Get started
Work

Integrated prognostic model for TP53‑mutated myeloid neoplasms across all myeloid neoplasm subtypes

Year: 2025
Type: conference-abstract
Source: Blood
DOI: 10.1182/blood-2025-2087
Authors: Devendra Hiwase, Steven Tessier, Kevin Hung, Rong He, Maymona Abdelmagid, Danielle Rud, Michelle Maritz, Aref Al-Kali, Naseema Gangat, Mrinal Patnaik, Abhishek Mangaonkar, Hosein Anani, Antoine Saliba, Nathan Punwani, James Foran, Dong Chen, Emmanuel Gnanamanickam, Hassan Alkhateeb, Dariusz Ladon, Monika Kutyna, Kebede Begna, Hamish Scott, Mehrdad Hefazi Torghabeh, Aasiya Matin, Kaaren Reichard, Cinthya Zepeda, Chris Hahn, William Hogan, Attilio Orazi, Daniel Arber, Chung Hoow Kok, Mithun Shah, Ayalew Tefferi
Institutions: Royal Adelaide Hospital, South Australian Health and Medical Research Institute, The University of Adelaide, Mayo Clinic, Mayo Clinic in Arizona, Mayo Clinic in Florida, South Australia Pathology, Texas Tech University, University of Chicago
Language: English
Subfield: Hematology
Field: Medicine
Open Access status: closed
OpenAlex ID: W4417017091
Cites:
Cited by:
Related to: